Fosun Pharma tumbles in debut; bodes ill for new deals

Shanghai Fosun Pharmaceutical (Group) Co Ltd fell sharply on its Hong Kong debut on Tuesday, underscoring concerns about weak investor appetite that could pressure new listings in the city in the coming months.

Shares of Shanghai Fosun, which raised US$512 million last week in the biggest Hong Kong listing in three months, tumbled as much as 12 per cent in early trading. That far underperformed a 0.3 per cent drop in the benchmark Hang Seng index.

via Business feed http://www.scmp.com/business/money/markets-investing/article/1073133/fosun-pharma-tumbles-debut-bodes-ill-new-deals